(Q51191354)

1 April 2018

title

EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. (English)

1 reference

1 April 2018

1 reference

M Kamiyama

1

1 reference

1 April 2018

A Pozzi

2

1 reference

1 April 2018

L Yang

3

1 reference

1 April 2018

L M DeBusk

4

1 reference

1 April 2018

R M Breyer

5

1 reference

1 April 2018

P C Lin

6

1 reference

1 April 2018

language of work or name

English

0 references

publication date

29 May 2006

1 reference

1 April 2018

published in

Oncogene

1 reference

1 April 2018

volume

25

1 reference

1 April 2018

page(s)

7019-7028

1 reference

1 April 2018

issue

53

1 reference

1 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209694

exact match

0 references

cites work

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Prostanoid receptors: subtypes and signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

MAPK (ERK2) kinase--a key target for NSAIDs-induced inhibition of gastric cancer cell proliferation and growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Endothelial cell confluence regulates cyclooxygenase-2 and prostaglandin E2 production that modulate motility.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Molecular angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Prostanoid receptors: structures, properties, and functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209694

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209694

1 reference

1 April 2018

PubMed ID

16732324

1 reference

1 April 2018